The field of regenerative medicine is uniquely positioned to fight the COVID-19 pandemic. The Regenerative Medicine Manufacturing Society and STEM CELLS Translational Medicine journal partnered to present this webinar featuring leaders working in the regenerative medicine field from academic and government institutions. The panelists discussed specifically what their institutions do to advance science to combat this dangerous pandemic.

Introduction - 00:00:00

Medicine Resources to Fight COVID-19, 00:12:00
Anthony Atala, M.D. Director, Wake Forest Institute for Regenerative Medicine (WFIRM)

NHLBI Efforts for Fighting COVID-19, 00:19:43
Martha Lundberg, Ph.D. Program Director, National Heart, Lung, and Blood Institute (NHLBI) at the NIH

Tissue Chips for Addressing COVID-19 Challenges, 00:27:07
Lucie Low, Ph.D. Scientific Program Manager, National Center for Advancing Translational Sciences (NCATS) at the NIH

Novel Cell-based COVID-19 Tools, 00:35:10
Mahendra Rao, M.D., Ph.D. CEO, panCELLa

CIRM Efforts for Fighting COVID-19, 00:46:22
Sohel Talib, Ph.D. Director of Therapeutics, CIRM

Panel Discussion with Speakers, 00:57:02

свернуть